The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Partnership aims to accelerate precision immunotherapy by leveraging AI-powered virtual cell models to identify which patients are most likely to benefit from BOT/BAL treatment Collaboration builds on ...

Before 2017, Zuckerberg San Francisco General Hospital – an urban, academic safety-net hospital within the San Francisco Health Network – struggled with some of the highest 30-day readmission rates in ...

Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death. While advances in surgery have improved safety, recurrence after hepatectomy ...

Geisinger and IBM this week announced this week that they've co-created a new predictive model to help clinicians flag sepsis risk using data from the integrated health system's electronic health ...

In this interview, discover how retina models are revolutionizing rare disease treatment and accelerating drug development. What are the biggest challenges in developing effective therapies for rare ...

Implementing predictive analytics can become one of the biggest competitive differentiators for any educational institution ...